AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine

Synapse

Volumn 31, Issue 4, 1999, Pages 256-262

  Carlezon Jr , William A ^a   Rasmussen, Kurt ^b   Nestler, Eric J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

AMPA; Glutamate; Locomotor activity; Opiates; Sensitization; State dependent learning

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; AMPHETAMINE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; KAINIC ACID RECEPTOR; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG SENSITIZATION; LOCOMOTION; MALE; NARCOTIC DEPENDENCE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STATE DEPENDENT LEARNING; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOQUINOLINES; MALE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TETRAZOLES;

EID: 0345003769     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990315)31:4<256::AID-SYN3>3.0.CO;2-E     Document Type: Article

References (43)

1. Bleakman D, Schoepp DD, Ballyk B, Bufton H, Sharpe EF, Thomas K, Ornstein PL, Kamboj RK. 1996. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinilone-3 carboxylic acid. Mol Pharmacol 49:581-585.
2. Carlezon WA Jr, Wise RA. 1993. Phencyclidine-induced potentiation of brain stimulation reward: Acute effects are not altered by repeated administration. Psychopharmacology 111:402-408.
3. Carlezon WA Jr, Mendrek A, Wise RA. 1995. MK-801 disrupts the expression but not the development of bromocriptine sensitization: A state-dependency interpretation. Synapse 20:1-9.
4. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ. 1997. Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814.
5. Henry DJ, White FJ. 1995. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15:6287-6299.
6. Horger BA, Shelton K, Schenk S. 1990. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707-711.
7. Jackson A, Koek W, Colpaert FC. 1992. NMDA antagonists make learning and recall state-dependent. Behav Pharmacol 3:415-421.
8. Jeziorski M, White FJ, Wolf ME. 1994. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16:137-147.
9. Jin S. 1998. AMPA-and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices. Neuropharmacology 36:1503-1510.
10. Kalivas PW, Alesdatter JE. 1993. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
11. Kalivas PW, Duffy P. 1995. D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
12. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
13. Kalivas PW, Weber B. 1988. Amphelamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095-1102.
14. Karler R, Calder LD, Chaudhry IA, Turkanis SA. 1989. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
15. Karler R, Calder LD, Turkanis SA. 1991a. DNQX blockade of amphetamine behavioral sensitization. Brain Res 552:295-300.
16. Karler R, Turkanis SA, Partlow LM, Calder LD. 1991b. Calcium channel blockers and behavioral sensitization. Life Sci 49:165-170.
17. Kest K, McLemore G, Kao B, Inturrisi CE. 1997. The competitive α-amino-3-hydroxy-5-methylisoxazole-4-proprionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. J Pharamacol Exp Ther 283:1249-1255.
18. Kuczenski R, Segal DS, Todd PK. 1997. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134:221-229.
19. Lett BT. 1989. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98:357-362.
20. Li Y, Vartanian AJ, White FJ, Xue C-J, Wolf ME. 1997. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology 134:266-276.
21. McLemore GL, Kest B, Inturrisi CE. 1997. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res 778:120-126.
22. Miserendino MJD, Guitart X, Terwilliger RZ, Chi S, Nestler EJ. 1993. Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague-Dawley rats. Mol Cell Neurosci 4:440-448.
23. Nabeshima T, Fukaya H, Yamaguchi K, Ishikawa K, Furukawa H, Kameyama T. 1987. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. Eur J Pharmacol 135:23-33.
24. Perugini M, Vezina P. 1994. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
25. Piazza PV, Deminiere JM, Le Moal M, Simon H. 1989. Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513.
26. Pierce RC, Bell K, Duffy P, Kalivas PW. 1996. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
27. Pudiak CM,Bozarth MA. 1993. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 53:1517-1524.
28. Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK. 1996. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology 15:497-505.
29. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-292.
30. Self DW, Nestler EJ. 1995. Molecular mechanisms of drug reinforcement and addition. Annu Rev Neurosci 18:463-495.
31. Sklair-Tavron L, Shi W-X, Lane SB, Harris HW, Bunney BS, Nestler EJ. 1996. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 93:11202-11207.
32. Stewart J, Druhan JP. 1993. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology 110:125-132.
33. Stewart J, Vezina P. 1989. Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495:401-406.
34. Vezina P, Stewart J. 1989. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120.
35. Vezina P, Stewart J. 1990. Amphetamine administered to the ventral tegmental area but not the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 516:99-106.
36. White FJ, Joshi A, Koeltzow TE, Hu X-T. 1998. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26-40.
37. Willetts J, Balster RL. 1988. Phencyclidine-like discriminative stimulus properties of MK-801 in rats. Eur J Pharmacol 146:167-169.
38. Wise RA, Leeb K. 1993. Psychomotor-stimulant sensitization: A unitary phenomenon? Behav Pharmacol 4:339-349.
39. Wise RA, Mendrek A, Carlezon WA Jr. 1996. MK-801 (Dizocilpine): Synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization. Synapse 22:362-368.
40. Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
41. Wolf ME, Khansa MR. 1991. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
42. Wolf ME, Dahlin SL, Hu X-T, Xue C-J, White K. 1995. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-D-aspartate antagonists. Neuroscience 69:417-439.
43. Zhang Z-F, Hu X-T, White FJ, Wolf ME. 1997. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281:699-706.